MedTrace Logo

Comparison of the Effectiveness of Sambiloto Herbs (Andrographis Paniculata) and Brisk Walking Exercise on Blood Glucose of Obese Patients

NCT06520501 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-09-19

No results posted yet for this study

Summary

Problem Formulation

1. Does herbal medicine sambiloto affect the blood glucose levels of obese sufferers?
2. Does brisk walking affect blood glucose levels in obese sufferers?
3. Does the combination of bitter herbal medicine and brisk walking have an effect on blood glucose levels in obese sufferers?
4. Is there a difference in the effectiveness between herbal bitter and brisk walking and the combination on blood glucose levels in obese sufferers?

Research Objectives

General Objectives :

The general aim of this research is to determine the difference in effectiveness between the herbal medicine Sambiloto and brisk walking as well as the combination on the blood glucose levels of obese sufferers.

Specific Objective :

1. Knowing the effect of herbal medicine Sambiloto on blood glucose in obese sufferers.
2. Knowing the effect of brisk walking on blood glucose in obese sufferers.
3. To determine the effect of the combination of herbal medicine Sambiloto and brisk walking on blood glucose levels in obese sufferers.

Conditions

  • MeSH

Interventions

DIETARY_SUPPLEMENT

Herbal Medicine Sambiloto

Jamu Sambiloto is herbal medicine obtained through products that already have a distribution permit and have a distribution permit registration number, with a consumption dose of 1 capul / day or 350 grams for 7 consecutive days.

BEHAVIORAL

Brisk Walking

Moderate activity that uses brisk walking techniques for 30 minutes at an average speed of up to 5 km/h or 100 steps per minute.

COMBINATION_PRODUCT

Brisk Walking and Herbal Medicine Sambiloto

Moderate activity that uses brisk walking techniques for 30 minutes at an average speed of up to 5 km/h or 100 steps per minute. Jamu Sambiloto is herbal medicine obtained through products that already have a distribution permit and have a distribution permit registration number, with a consumption dose of 1 capul / day or 350 grams for 7 consecutive days

Sponsors & Collaborators

  • Universitas Palangka Raya

    lead OTHER

Principal Investigators

  • Agnes Veronica Agustin · Universitas Palangka Raya

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
39 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-04
Primary Completion
2024-09-14
Completion
2024-10-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06520501 on ClinicalTrials.gov